Literature DB >> 32839526

Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder.

S Stevens Negus1, Matthew L Banks2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32839526      PMCID： PMC7547654          DOI： 10.1038/s41386-020-00815-4

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  52 in total

Review 1.  Dopamine, learning and motivation.

Authors:  Roy A Wise
Journal:  Nat Rev Neurosci       Date:  2004-06       Impact factor: 34.870

Review 2.  Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Authors:  John Grabowski; James Shearer; John Merrill; S Stevens Negus
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

3.  Use of Preclinical Drug vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine Addiction.

Authors:  Matthew L Banks; Blake A Hutsell; Kathryn L Schwienteck; S Stevens Negus
Journal:  Curr Treat Options Psychiatry       Date:  2015-06

Review 4.  Inflammatory and Neuropathic Pain From Bench to Bedside: What Went Wrong?

Authors:  Robert P Yezierski; Per Hansson
Journal:  J Pain       Date:  2018-01-04       Impact factor: 5.820

5.  Lorcaserin Departs, Leaving More Questions than Answers.

Authors:  Rekha Kumar; Donna Ryan
Journal:  Obesity (Silver Spring)       Date:  2020-04-22       Impact factor: 5.002

Review 6.  Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.

Authors:  Leonard L Howell; Kathryn A Cunningham
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

7.  Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies.

Authors:  Nora D Volkow; Joanna S Fowler; Gene-Jack Wang; Rita Z Goldstein
Journal:  Neurobiol Learn Mem       Date:  2002-11       Impact factor: 2.877

Review 8.  The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders.

Authors:  Gregory T Collins; Lisa R Gerak; Charles P France
Journal:  Neuropharmacology       Date:  2017-12-12       Impact factor: 5.250

Review 9.  Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.

Authors:  Marcy J Bubar; Kathryn A Cunningham
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

10.  Design and synthesis of an irreversible dopamine-sparing cocaine antagonist.

Authors:  Peter C Meltzer; Shanghao Liu; Heather Blanchette; Paul Blundell; Bertha K Madras
Journal:  Bioorg Med Chem       Date:  2002-11       Impact factor: 3.641
View more
  8 in total

1.  The importance of examining sex differences in animal models validated to induce an addiction-like phenotype.

Authors:  Eleanor Blair Towers; Wendy J Lynch
Journal:  Pharmacol Biochem Behav       Date:  2021-08-17       Impact factor: 3.697

2.  Effects of buprenorphine/lorcaserin mixtures on preference for heroin, cocaine, or saline over food using a concurrent choice procedure in rhesus monkeys.

Authors:  Lisa R Gerak; Charles P France
Journal:  Drug Alcohol Depend       Date:  2021-08-28       Impact factor: 4.852

3.  Logical fallacies and misinterpretations that hinder progress in translational addiction neuroscience.

Authors:  Justin C Strickland; William W Stoops; Matthew L Banks; Cassandra D Gipson
Journal:  J Exp Anal Behav       Date:  2022-04-01       Impact factor: 2.215

4.  A drug-vs-food "choice" self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disorders.

Authors:  E Andrew Townsend; Kathryn L Schwienteck; Hannah L Robinson; Stephen T Lawson; Matthew L Banks
Journal:  J Neurosci Methods       Date:  2021-03-08       Impact factor: 2.390

Review 5.  Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders.

Authors:  Ken W Grasing; Kim Burnell; Alok De
Journal:  Behav Pharmacol       Date:  2022-03-23       Impact factor: 2.277

6.  Modafinil reduces smoked cocaine self-administration in humans: effects vary as a function of cocaine 'priming' and cost.

Authors:  Margaret Haney; Eric Rubin; Rebecca K Denson; Richard W Foltin
Journal:  Drug Alcohol Depend       Date:  2021-02-08       Impact factor: 4.492

7.  Pilot study of extended-release lorcaserin for cocaine use disorder among men who have sex with men: A double-blind, placebo-controlled randomized trial.

Authors:  Glenn-Milo Santos; Janet Ikeda; Phillip Coffin; John E Walker; Tim Matheson; Matthew McLaughlin; Jennifer Jain; Eric Vittinghoff; Steven L Batki
Journal:  PLoS One       Date:  2021-07-15       Impact factor: 3.752

8.  Safety and Preliminary Efficacy of Lorcaserin for Cocaine Use Disorder: A Phase I Randomized Clinical Trial.

Authors:  Sade E Johns; Lori Keyser-Marcus; Antonio Abbate; Edward Boone; Benjamin Van Tassell; Kathryn A Cunningham; Noelle C Anastasio; Justin L Poklis; Tatiana Ramey; F Gerard Moeller
Journal:  Front Psychiatry       Date:  2021-07-02       Impact factor: 4.157
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.